Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2310-2021Class II

OPTI SARS-CoV-2 RT-PCR Test, REF Numbers: a) 99-57003 b) 99-57004

Opti Medical Systems Inc / initiated 2021-06-25 / Open, Classified / root cause: manufacturing process

OPTI Medical Systems, Inc began a recall of OPTI SARS-CoV-2 RT-PCR Test, REF Numbers: a) 99-57003 b) 99-57004 on . FDA classified it as Class II and gives the reason as "The firm identified a precipitation issue which may cause late Ct reactors (a false positive result) with a rate of 5 to 10% for affected vials of RNA Master Mix". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2310-2021
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Opti Medical Systems Inc
Product
OPTI SARS-CoV-2 RT-PCR Test, REF Numbers: a) 99-57003 b) 99-57004
Product code
QJR Reagents, 2019-Novel Coronavirus Nucleic Acid
Reason for recall
The firm identified a precipitation issue which may cause late Ct reactors (a false positive result) with a rate of 5 to 10% for affected vials of RNA Master Mix.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
/The firm disseminated a technical bulletin beginning on 06/25/2021 by email identifying the /problem and providing additional instructions to be implemented when using the product.
Quantity in commerce
3552 kits
Distribution
Maine, New York, Alabama, Pennsylvania, Florida, Illinois, New Jersey, Connecticut, Georgia, Puerto Rico, Costa Rica, Hong Kong, Philippines, Barbados
Product codes and lots
a) 99-57003, Lot Numbers: 20808, 20812, 20813 b) 99-57004, Lot Numbers: 20881, 20901, 211013

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2310-2021
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2310-2021Class IIOngoingVoluntary: Firm initiated